Protagonist Therapeutics Inc

XNAS: PTGX

Turnaround Potential

Download real time

52.65 -0.40 (-0.75%)

117.38% Gain from 52W Low

3.7M XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

3,231.9

Market Cap

High in industry

-0.6

Beta 1Year

Very Low volatility

Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 10 analysts

Protagonist Therapeutics Inc has a share price target of US$ 69, revenue growth forecast of -77.3%, and profit growth estimate of -129.6% for FY25, based on top 10 analyst calls.

Forecaster Screeners